Skip to main content

90th Anniversary of the 1932 Sherrington and Adrian Nobel Prize: Molecular Pathways of Synaptic Transmission Regulation

41kviews
Editorial22 August 2023
Editorial: 90th anniversary of the 1932 Sherrington and Adrian Nobel prize: molecular pathways of synaptic transmission regulation

In human brain, there are about 86 billion neurons that connect each other to form sophisticated networks (Li and Sheng, 2022). The communication between neurons largely relies on synaptic transmission. A classic neuronal synaptic transmission process begins with the formation of action potential which depolarizes presynaptic membranes to activate the voltage-gated calcium channels, and this will result in triggering the exocytosis of the synaptic vesicles and release of the neurotransmitters into the synaptic junction (Chapman, 2018; Madrigal et al., 2019). At the postsynaptic structure, specialization senses neurotransmitters via diverse receptors including cell-adhesion molecules (Jang et al., 2017; Südhof, 2018).

Impaired interactions of the trans-synaptic cell-adhesion molecules have been implicated in neuropsychiatry disorders (Südhof, 2018). Synaptic plasticity, a vital contributor to the long-term activity-dependent changes in neural circuits, plays a significant role in processes such as learning and memory (Südhof, 2018), specifically, N-methyl-D-aspartate receptor (NMDAR) -dependent long term potentiation has shown to be largely involved (Südhof, 2018). Energy is also a crucial component of synaptic transmission (synaptoenergetics). Dysregulation of energy regulation in synaptic transmission is linked to several neurological disorders, involving bioenergetics failure and synaptic dysfunction (Li and Sheng, 2022). Synaptoenergetics failure can cause conditions such as Parkinson disease, amyotrophic lateral sclerosis, Alzheimer disease, Huntington disease, Hereditary spastic paraplegia, Progressive myoclonus epilepsy, Schizophrenia, Tuberous sclerosis complex, Charcot–Marie–Tooth disease type 2A, Dominant optic atrophy, and Fmr1- KO mice ((Li and Sheng, 2022). Overall, deficit in synaptic transmission can lead to diseases such as epilepsy, intellectual disability/global developmental delay, attention-deficit/hyperactivity disorder, depression, and autism spectrum disorder (ASD) (Fukata and Fukata, 2017; Telias, 2019; Kessi et al., 2020, 2021, 2022a, 2022b; Yan and Rein, 2022).

The aim of this research topic is to shed light on the current advances in understanding the basic mechanisms of neuron function, action potential generation, signal integration and transmission across the entire central nervous system. This will further enhance our comprehension of how biological mechanisms and physiological properties contribute to the global information processing. The collection of five articles provides valuable updates and insights into various aspects related to synaptic transmission.

In one study, a mutation (c.892C>T, p.Arg298Trp) in the NACC1 gene was linked to severe neurological symptoms including epilepsy and intellectual disability. Investigating this novel association, Daniel et al explored how the mutation could alter brain function by examining the neurotransmission in glutamatergic mouse neurons expressing the human mutant NACC1 (Nacc1-R284W) (Daniel et al., 2023). They observed that the expression of Nacc1-R284W in mouse impaired glutamatergic neurotransmission in a cell-autonomous manner. In addition, they discovered (SYNaptic GTPase Activating Protein) SynGAP1, glutamate kainate receptor subunit 2 (GluK2), and several small ubiquitin-like modifier (SUMO) protein ligases (E3) (SUMO E3) as novel Nacc1 interactive proteins. Nacc1-R284W displayed reduced binding capacity to SynGAP1 and GluK2, and augmented SUMOylation. Their findings suggest a role for Nacc1 in regulating glutamatergic neurotransmission (Daniel et al., 2023).

Another study by Ramsay et al assessed the synaptic nano-architecture under situations where presynaptic neurotransmitter discharge was blocked before and during synaptogenesis (Ramsay et al., 2023). Their study emphasized that the neurotransmitter release was not mandatory for the formation of excitatory or inhibitory synapses. Despite this, basic features of synaptic nano-architecture, including assembly of receptors and scaffolds into trans-synaptically aligned structures, were found to be intrinsic properties that can be further regulated by subsequent activity-dependent mechanisms (Ramsay et al., 2023).

Liu et al explored the mechanism by which glucagon-like peptide-1 (GLP-1) controls mouse cerebellar Purkinje cell activity in vitro (Liu et al., 2023). Their study revealed that GLP-1 plays an important role in moderating cerebellar function by regulating the spike firing activity of mouse cerebellar Purkinje cell (Liu et al., 2023).

Furthermore, Bykhovskaia et al reviewed and discussed how Drosophila transgenic lines that express postsynaptically tethered calcium ions sensor GCaMP enables the exploration of the evoked and spontaneous transmission at single active zones (Bykhovskaia, 2023). This review helps the understanding of the properties of both release components, including decoupling between the evoked and spontaneous release (Bykhovskaia, 2023).

Lastly, Ge et al summarized the GluN2B-containing NMDAR pharmacology and its key physiological functions, emphasizing its importance during both health and disease states (Ge and Wang, 2023). They summarized the role of the GluN2B-containing NMDAR in intellectual disability, ASD, schizophrenia, stroke, traumatic brain injury, epilepsy, major depressive disorder, Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease (Ge and Wang, 2023).

Altogether, this Frontier in Molecular Neuroscience Research Topic provides updates on various aspect of glutamatergic neurotransmission, GluN2B-containing NMDAR pharmacology in health and disease states, basic features of synaptic nano-architecture, mechanism of GLP1 in cerebellar function exploration of evoked and spontaneous transmission. We express our gratitude to each author and hope that this Research Topic will encourage further exploration of the molecular mechanisms in synaptic transmission regulation.

1,876 views

An intellectual-disability-associated mutation of the transcriptional regulator NACC1 impairs glutamatergic neurotransmission
ORIGINAL RESEARCH
14 July 2023
An intellectual-disability-associated mutation of the transcriptional regulator NACC1 impairs glutamatergic neurotransmission
James A. Daniel, 7 more and Marilyn Tirard
Advances in genome sequencing technologies have favoured the identification of rare de novo mutations linked to neurological disorders in humans. Recently, a de novo autosomal dominant mutation in NACC1 was identified (NM_052876.3: c.892C>T, NP_443108.1; p.Arg298Trp), associated with severe neurological symptoms including intellectual disability, microcephaly, and epilepsy. As NACC1 had never before been associated with neurological diseases, we investigated how this mutation might lead to altered brain function. We examined neurotransmission in autaptic glutamatergic mouse neurons expressing the murine homolog of the human mutant NACC1, i.e. Nacc1-R284W. We observed that expression of Nacc1-R284W impaired glutamatergic neurotransmission in a cell-autonomous manner, likely through a dominant negative mechanism. Furthermore, by screening for Nacc1 interaction targets in the brain, we identified SynGAP1, GluK2, and several SUMO E3 ligases as novel Nacc1 interaction partners. At a biochemical level, Nacc1-R284W exhibited reduced binding to SynGAP1 and GluK2, and also showed greatly increased SUMOylation. Ablating the SUMOylation of Nacc1-R284W partially restored its interaction with SynGAP1 but did not restore binding to GluK2A. Overall, these data indicate a role for Nacc1 in regulating glutamatergic neurotransmission, which is substantially impaired by the expression of a disease-associated Nacc1 mutant. This study provides the first functional insights into potential deficits in neuronal function in patients expressing the de novo mutant NACC1 protein.

8,934 views

14 citations

ORIGINAL RESEARCH
5 April 2023
GLP-1 enhances hyperpolarization-activated currents of mouse cerebellar Purkinje cell in vitro
Yang Liu, 6 more and De-Lai Qiu

4,112 views

4 citations